Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Balistrieri

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
What can we learn from pathophysiology and therapeutic targetable pathways from all genetic causes and associations in PH?Angela Balistrieri, Eckart De Bie, Mark Toshner
Physiological Reviews|November 24, 2022
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca<sup>2+</sup> signalingAngela Balistrieri, Ayako Makino, Jason X-J Yuan
American Journal of Physiology. Cell Physiology|August 9, 2018
Alterations in human neutrophil function caused by bisphenol AAngela Balistrieri, Laura Hobohm, Trisha Srivastava, et al.
JACC. Asia|January 30, 2023
Pathogenic Mechanisms of Pulmonary Arterial Hypertension: Homeostasis Imbalance of Endothelium-Derived Relaxing and Contracting FactorsJinsheng Zhu, Lei Yang, Yangfan Jia, et al.
American Journal of Physiology. Cell Physiology|March 8, 2018
Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic miceMinglin Pan, Ying Han, Aninda Basu, et al.
Hypertension (Dallas, Tex. : 1979)|January 24, 2018
STIM2 (Stromal Interaction Molecule 2)-Mediated Increase in Resting Cytosolic Free Ca<sup>2+</sup> Concentration Stimulates PASMC Proliferation in Pulmonary Arterial HypertensionShanshan Song, Shane G Carr, Kimberly M McDermott, et al.
British Journal of Pharmacology|August 30, 2017
Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertensionKang Wu, Qian Zhang, Xiongting Wu, et al.
JACC. Basic to Translational Science|January 10, 2019
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary HypertensionHaiyang Tang, Kang Wu, Jian Wang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 27, 2021
TRPC6, a therapeutic target for pulmonary hypertensionPritesh P Jain, Ning Lai, Mingmei Xiong, et al.
Frontiers in Physiology|August 19, 2021
Upregulation of Calcium Homeostasis Modulators in Contractile-To-Proliferative Phenotypical Transition of Pulmonary Arterial Smooth Muscle CellsMarisela Rodriguez, Jiyuan Chen, Pritesh P Jain, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
What can we learn from pathophysiology and therapeutic targetable pathways from all genetic causes and associations in PH?Angela Balistrieri, Eckart De Bie, Mark Toshner
Physiological Reviews|November 24, 2022
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca<sup>2+</sup> signalingAngela Balistrieri, Ayako Makino, Jason X-J Yuan
American Journal of Physiology. Cell Physiology|August 9, 2018
Alterations in human neutrophil function caused by bisphenol AAngela Balistrieri, Laura Hobohm, Trisha Srivastava, et al.
JACC. Asia|January 30, 2023
Pathogenic Mechanisms of Pulmonary Arterial Hypertension: Homeostasis Imbalance of Endothelium-Derived Relaxing and Contracting FactorsJinsheng Zhu, Lei Yang, Yangfan Jia, et al.
American Journal of Physiology. Cell Physiology|March 8, 2018
Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic miceMinglin Pan, Ying Han, Aninda Basu, et al.
Hypertension (Dallas, Tex. : 1979)|January 24, 2018
STIM2 (Stromal Interaction Molecule 2)-Mediated Increase in Resting Cytosolic Free Ca<sup>2+</sup> Concentration Stimulates PASMC Proliferation in Pulmonary Arterial HypertensionShanshan Song, Shane G Carr, Kimberly M McDermott, et al.
British Journal of Pharmacology|August 30, 2017
Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertensionKang Wu, Qian Zhang, Xiongting Wu, et al.
JACC. Basic to Translational Science|January 10, 2019
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary HypertensionHaiyang Tang, Kang Wu, Jian Wang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 27, 2021
TRPC6, a therapeutic target for pulmonary hypertensionPritesh P Jain, Ning Lai, Mingmei Xiong, et al.
Frontiers in Physiology|August 19, 2021
Upregulation of Calcium Homeostasis Modulators in Contractile-To-Proliferative Phenotypical Transition of Pulmonary Arterial Smooth Muscle CellsMarisela Rodriguez, Jiyuan Chen, Pritesh P Jain, et al.
Pageof 2